parallel randomized trial
NCT06256562
A Multicenter, Randomized, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Chinese Obese/Overweight Patients
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | Bofanglutide 12 mg injection every 2 weeks Bofanglutide 12 mg Q2W | lifestyle: standard | 52 | 52 | |
| A2 | Bofanglutide 18 mg injection every 2 weeks Bofanglutide 18 mg Q2W | lifestyle: standard | 53 | 53 | |
| A3 | Bofanglutide 24 mg injection every 2 weeks Bofanglutide 24 mg Q2W | lifestyle: standard | 52 | 52 | |
| A4 | Bofanglutide 48 mg injection every 2 weeks Bofanglutide 48 mg Q2W | lifestyle: standard | 64 | 64 | |
| A5 | Bofanglutide 24 mg injection once weekly Bofanglutide 24 mg QW | lifestyle: standard | 53 | 53 | |
| A6 | Placebo Placebo | lifestyle: standard | 66 | 66 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Bofanglutide 12 mg injection every 2 weeks A1 | Bofanglutide 18 mg injection every 2 weeks A2 | Bofanglutide 24 mg injection every 2 weeks A3 | Bofanglutide 48 mg injection every 2 weeks A4 | Bofanglutide 24 mg injection once weekly A5 | Placebo A6 |
|---|---|---|---|---|---|---|---|
| age | mean (years) | 32.3 | 33.0 | 33.7 | 32.8 | 32.8 | 33.7 |
| age | sd (years) | 7.0 | 7.6 | 6.3 | 7.8 | 7.4 | 7.2 |
| asian | n | 52 | 53 | 52 | 64 | 53 | 66 |
| asian | percent | 100 | 100 | 100 | 100 | 100 | 100 |
| bmi: 24 to less than 28 | n | 1 | 5 | 3 | 8 | 5 | 5 |
| bmi: 24 to less than 28 | percent | 1.9 | 9.4 | 5.8 | 12.5 | 9.4 | 7.6 |
| bmi: 28 or more | n | 51 | 48 | 49 | 56 | 48 | 61 |
| bmi: 28 or more | percent | 98.1 | 90.6 | 94.2 | 87.5 | 90.6 | 92.4 |
| bmi | mean (kg/m2) | 33.7 | 32.4 | 33.3 | 33.0 | 33.1 | 33.8 |
| bmi | sd (kg/m2) | 4.9 | 4.1 | 4.1 | 4.9 | 4.5 | 5.0 |
| female | n | 20 | 26 | 20 | 35 | 23 | 31 |
| female | percent | 38.5 | 49.1 | 38.5 | 54.7 | 43.4 | 47.0 |
| hba1c | mean (percent) | 5.60 | 5.48 | 5.57 | 5.54 | 5.67 | 5.62 |
| hba1c | sd (percent) | 0.39 | 0.41 | 0.42 | 0.34 | 0.49 | 0.37 |
| sbp | mean (mmHg) | 122.5 | 121.5 | 122.9 | 123.4 | 119.9 | 119.7 |
| sbp | sd (mmHg) | 9.60 | 11.41 | 10.53 | 10.37 | 11.44 | 10.31 |
| waist | mean (cm) | 107.7 | 105.1 | 108.1 | 105.5 | 106.3 | 108.2 |
| waist | sd (cm) | 13.2 | 11.2 | 11.0 | 14.0 | 12.2 | 13.1 |
| weight | mean (kg) | 97.22 | 93.01 | 97.17 | 94.87 | 94.52 | 96.90 |
| weight | sd (kg) | 21.22 | 14.59 | 17.22 | 23.17 | 18.60 | 21.46 |
Analyses this trial contributes to
- Systolic blood pressure changeOverweight or obesity without diabetes (adults); weeks 20 to 40 (target week 26); descriptive only
- Systolic blood pressure changeOverweight or obesity without diabetes (adults); weeks 20 to 40 (target week 26); descriptive only
- Percent body weight changeOverweight or obesity without diabetes (adults); weeks 20 to 40 (target week 26); network meta-analysis
- Percent body weight changeOverweight or obesity without diabetes (adults); weeks 20 to 40 (target week 26); network meta-analysis
- Percent body weight changeOverweight or obesity without diabetes (adults); weeks 20 to 40 (target week 26); network meta-analysis
- Percent body weight changeOverweight or obesity without diabetes (adults); weeks 20 to 40 (target week 26); network meta-analysis
- SF-36 physical component summary changeOverweight or obesity without diabetes (adults); weeks 20 to 130 (target week 52); network meta-analysis
- SF-36 physical component summary changeOverweight or obesity without diabetes (adults); weeks 20 to 130 (target week 52); network meta-analysis
- Serious adverse eventsOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- Serious adverse eventsOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- NauseaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- NauseaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- VomitingOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- VomitingOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- DiarrheaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- DiarrheaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- Suicidal ideation or behaviorOverweight or obesity without diabetes (adults); longest follow-up; descriptive only
- Suicidal ideation or behaviorOverweight or obesity without diabetes (adults); longest follow-up; descriptive only
- Death by suicideOverweight or obesity without diabetes (adults); longest follow-up; descriptive only
- Death by suicideOverweight or obesity without diabetes (adults); longest follow-up; descriptive only
Results
228 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (11 lines; O05)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 vs A6 | md | -3.31 mmHg | -7.47 to 0.84 | treatment policy; modified itt; R0002409:Supplement Table S4 | ||
| 30 | A1 | change | -3.42 mmHg | 1.56 | 52 | treatment policy; modified itt; R0002409:Supplement Table S4 | |
| 30 | A2 | change | -8.13 mmHg | 1.51 | 53 | treatment policy; modified itt; R0002409:Supplement Table S4 | |
| 30 | A2 vs A6 | md | -8.03 mmHg | -12.17 to -3.89 | treatment policy; modified itt; R0002409:Supplement Table S4 | ||
| 30 | A3 | change | -4.82 mmHg | 1.58 | 52 | treatment policy; modified itt; R0002409:Supplement Table S4 | |
| 30 | A3 vs A6 | md | -4.71 mmHg | -8.84 to -0.58 | treatment policy; modified itt; R0002409:Supplement Table S4 | ||
| 30 | A4 vs A6 | md | -10.05 mmHg | -14.12 to -5.98 | treatment policy; modified itt; R0002409:Supplement Table S4 | ||
| 30 | A4 | change | -10.16 mmHg | 1.54 | 64 | treatment policy; modified itt; R0002409:Supplement Table S4 | |
| 30 | A5 vs A6 | md | -6.85 mmHg | -11.16 to -2.53 | treatment policy; modified itt; R0002409:Supplement Table S4 | ||
| 30 | A5 | change | -6.95 mmHg | 1.64 | 53 | treatment policy; modified itt; R0002409:Supplement Table S4 | |
| 30 | A6 | change | -0.10 mmHg | 1.54 | 66 | treatment policy; modified itt; R0002409:Supplement Table S4 |
Percent body weight change (74 lines; O10)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | percent change | -11.15 percent | 1.04 | 41 | not stated; per protocol; R0002409:Supplement Table S2 | |
| 30 | A1 | percent change | -9.98 percent | 0.94 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A1 vs A6 | md | -8.57 percent | -11.03 to -6.10 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A1 vs A6 | md | -10.17 percent | -12.86 to -7.47 | not stated; per protocol; R0002409:Supplement Table S2 | ||
| 30 | A1 vs A6 | md | -9.05 percent | -11.50 to -6.59 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A1 vs A6 | md | -8.60 percent | -11.18 to -6.01 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A1 | percent change | -0.94 percent | -22.30 to 20.41 | treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3 | ||
| 30 | A1 | percent change | -10.25 percent | -12.34 to -8.15 | treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3 | ||
| 30 | A1 | percent change | -9.75 percent | 0.99 | 52 | treatment policy; modified itt; R0002409:Table 2 | |
| 30 | A1 | percent change | -7.79 percent | -10.08 to -5.49 | treatment policy; modified itt; sex:male; R0002409:Supplement Table S3 | ||
| 30 | A1 | percent change | -12.65 percent | -16.00 to -9.29 | treatment policy; modified itt; sex:female; R0002409:Supplement Table S3 | ||
| 30 | A1 | percent change | -7.83 percent | -12.61 to -3.05 | treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3 | ||
| 30 | A1 | percent change | -9.72 percent | 0.94 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A2 | percent change | -11.59 percent | -13.75 to -9.43 | treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3 | ||
| 30 | A2 | percent change | -15.45 percent | -19.45 to -11.45 | treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3 | ||
| 30 | A2 | percent change | -14.02 percent | -24.48 to -3.57 | treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3 | ||
| 30 | A2 | percent change | -12.50 percent | 0.93 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A2 | percent change | -13.22 percent | 0.95 | 49 | not stated; per protocol; R0002409:Supplement Table S2 | |
| 30 | A2 | percent change | -12.74 percent | 0.91 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A2 vs A6 | md | -11.35 percent | -13.80 to -8.89 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A2 vs A6 | md | -12.23 percent | -14.80 to -9.67 | not stated; per protocol; R0002409:Supplement Table S2 | ||
| 30 | A2 vs A6 | md | -11.81 percent | -14.22 to -9.39 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A2 | percent change | -11.85 percent | -14.33 to -9.37 | treatment policy; modified itt; sex:male; R0002409:Supplement Table S3 | ||
| 30 | A2 | percent change | -13.52 percent | -16.35 to -10.68 | treatment policy; modified itt; sex:female; R0002409:Supplement Table S3 | ||
| 30 | A2 | percent change | -12.55 percent | 0.96 | 53 | treatment policy; modified itt; R0002409:Table 2 | |
| 30 | A2 vs A6 | md | -11.39 percent | -13.92 to -8.87 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 vs A6 | md | -12.19 percent | -14.65 to -9.73 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A3 | percent change | -14.85 percent | -18.08 to -11.62 | treatment policy; modified itt; sex:female; R0002409:Supplement Table S3 | ||
| 30 | A3 vs A6 | md | -12.50 percent | -15.07 to -9.94 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 | percent change | -13.82 percent | 0.93 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A3 | percent change | -14.25 percent | 1.01 | 43 | not stated; per protocol; R0002409:Supplement Table S2 | |
| 30 | A3 | percent change | -13.40 percent | -15.52 to -11.27 | treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3 | ||
| 30 | A3 | percent change | -13.34 percent | 0.94 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A3 | percent change | -22.70 percent | -34.79 to -10.61 | treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3 | ||
| 30 | A3 | percent change | -13.86 percent | -18.37 to -9.35 | treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3 | ||
| 30 | A3 vs A6 | md | -12.89 percent | -15.32 to -10.45 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A3 vs A6 | md | -13.27 percent | -15.93 to -10.61 | not stated; per protocol; R0002409:Supplement Table S2 | ||
| 30 | A3 | percent change | -12.86 percent | -15.15 to -10.57 | treatment policy; modified itt; sex:male; R0002409:Supplement Table S3 | ||
| 30 | A3 | percent change | -13.66 percent | 0.97 | 52 | treatment policy; modified itt; R0002409:Table 2 | |
| 30 | A4 | percent change | -16.04 percent | -18.19 to -13.89 | treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3 | ||
| 30 | A4 | percent change | -15.09 percent | 0.84 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A4 | percent change | -17.29 percent | 0.99 | 45 | not stated; per protocol; R0002409:Supplement Table S2 | |
| 30 | A4 | percent change | -17.57 percent | 0.87 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A4 vs A6 | md | -13.94 percent | -16.27 to -11.61 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A4 vs A6 | md | -16.30 percent | -18.93 to -13.68 | not stated; per protocol; R0002409:Supplement Table S2 | ||
| 30 | A4 vs A6 | md | -16.64 percent | -19.00 to -14.28 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A4 | percent change | -16.09 percent | 0.94 | 64 | treatment policy; modified itt; R0002409:Table 2 | |
| 30 | A4 vs A6 | md | -14.94 percent | -17.45 to -12.42 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 | percent change | -17.74 percent | -23.57 to -11.92 | treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3 | ||
| 30 | A4 | percent change | -16.01 percent | -20.41 to -11.61 | treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3 | ||
| 30 | A4 | percent change | -16.94 percent | -19.59 to -14.29 | treatment policy; modified itt; sex:female; R0002409:Supplement Table S3 | ||
| 30 | A4 | percent change | -15.03 percent | -17.61 to -12.44 | treatment policy; modified itt; sex:male; R0002409:Supplement Table S3 | ||
| 30 | A5 | percent change | -16.86 percent | -25.67 to -8.04 | treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3 | ||
| 30 | A5 | percent change | -18.82 percent | -21.91 to -15.73 | treatment policy; modified itt; sex:female; R0002409:Supplement Table S3 | ||
| 30 | A5 vs A6 | md | -15.54 percent | -18.10 to -12.98 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 | percent change | -17.30 percent | 0.93 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A5 | percent change | -17.78 percent | 1.01 | 43 | not stated; per protocol; R0002409:Supplement Table S2 | |
| 30 | A5 | percent change | -16.28 percent | 0.93 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A5 | percent change | -16.69 percent | 0.98 | 53 | treatment policy; modified itt; R0002409:Table 2 | |
| 30 | A5 | percent change | -15.10 percent | -17.48 to -12.72 | treatment policy; modified itt; sex:male; R0002409:Supplement Table S3 | ||
| 30 | A5 | percent change | -16.36 percent | -18.58 to -14.14 | treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3 | ||
| 30 | A5 | percent change | -17.69 percent | -21.79 to -13.59 | treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3 | ||
| 30 | A5 vs A6 | md | -16.37 percent | -18.81 to -13.93 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A5 vs A6 | md | -16.80 percent | -19.45 to -14.14 | not stated; per protocol; R0002409:Supplement Table S2 | ||
| 30 | A5 vs A6 | md | -15.12 percent | -17.57 to -12.67 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A6 | percent change | -1.15 percent | 0.87 | 66 | treatment policy; modified itt; R0002409:Table 2 | |
| 30 | A6 | percent change | 1.85 percent | -2.14 to 5.85 | treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3 | ||
| 30 | A6 | percent change | -0.93 percent | 0.83 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A6 | percent change | -0.99 percent | 0.91 | 53 | not stated; per protocol; R0002409:Supplement Table S2 | |
| 30 | A6 | percent change | -1.16 percent | 0.83 | not stated; modified itt; R0002409:Supplement Table S2 | ||
| 30 | A6 | percent change | -2.07 percent | -4.00 to -0.14 | treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3 | ||
| 30 | A6 | percent change | -1.18 percent | -3.86 to 1.50 | treatment policy; modified itt; sex:female; R0002409:Supplement Table S3 | ||
| 30 | A6 | percent change | 3.29 percent | -3.86 to 10.45 | treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3 | ||
| 30 | A6 | percent change | -1.11 percent | -3.29 to 1.07 | treatment policy; modified itt; sex:male; R0002409:Supplement Table S3 |
Weight loss of 5 percent or more (11 lines; O11A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | responders | 74.0 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A1 vs A6 | rd | 58.4 | 43.5 to 73.3 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 | responders | 87.5 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 vs A6 | rd | 71.7 | 58.8 to 84.6 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 | responders | 89.1 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 vs A6 | rd | 73.7 | 62.1 to 85.4 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 | responders | 96.8 | 64 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 vs A6 | rd | 81.6 | 72.5 to 90.7 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 vs A6 | rd | 77.2 | 65.6 to 88.8 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 | responders | 93.0 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A6 | responders | 18.5 | 66 | treatment policy; modified itt; R0002409:Table 2 |
Weight loss of 10 percent or more (11 lines; O11B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | responders | 51.9 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A1 vs A6 | rd | 46.0 | 32.7 to 59.2 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 | responders | 62.2 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 vs A6 | rd | 55.8 | 42.5 to 69.0 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 | responders | 74.7 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 vs A6 | rd | 68.9 | 54.7 to 83.2 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 | responders | 82.7 | 64 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 vs A6 | rd | 81.3 | 70.4 to 92.3 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 | responders | 88.7 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 vs A6 | rd | 82.1 | 71.4 to 92.9 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A6 | responders | 6.7 | 66 | treatment policy; modified itt; R0002409:Table 2 |
Weight loss of 15 percent or more (11 lines; O11C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | responders | 25.7 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A1 vs A6 | rd | 20.1 | 7.5 to 32.7 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 | responders | 36.4 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 vs A6 | rd | 32.5 | 20.3 to 44.7 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 | responders | 42.4 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 vs A6 | rd | 37.6 | 22.5 to 52.8 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 vs A6 | rd | 59.2 | 46.2 to 72.2 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 | responders | 61.5 | 64 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 | responders | 64.5 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 vs A6 | rd | 60.7 | 47.2 to 74.1 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A6 | responders | 3.9 | 66 | treatment policy; modified itt; R0002409:Table 2 |
Weight loss of 20 percent or more (11 lines; O11D)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | responders | 9.0 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A1 vs A6 | rd | 4.7 | -5.6 to 15.0 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 | responders | 16.7 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A2 vs A6 | rd | 13.6 | 3.9 to 23.3 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 | responders | 19.4 | 52 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A3 vs A6 | rd | 16.7 | 4.7 to 28.8 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 | responders | 39.2 | 64 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A4 vs A6 | rd | 37.3 | 23.9 to 50.6 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 | responders | 37.3 | 53 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A5 vs A6 | rd | 34.3 | 20.1 to 48.4 | treatment policy; modified itt; R0002409:Table 2 | ||
| 30 | A6 | responders | 3.5 | 66 | treatment policy; modified itt; R0002409:Table 2 |
All cause mortality (6 lines; O20)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A2 | events | 0 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A3 | events | 0 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A4 | events | 0 / 64 | not stated; safety; R0002409:Table 3 | ||||
| A5 | events | 0 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A6 | events | 0 / 66 | not stated; safety; R0002409:Table 3 |
Hospitalization for heart failure (1 lines; O23)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A4 | events | 0 / 64 | not stated; safety; R0002409:Table 3 |
SF-36 physical component summary change (11 lines; O24A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | change | 2.99 points | 0.57 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A1 vs A6 | md | 1.32 points | -0.18 to 2.82 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A2 | change | 3.77 points | 0.544 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A2 vs A6 | md | 2.10 points | 0.65 to 3.55 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A3 | change | 3.23 points | 0.55 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A3 vs A6 | md | 1.56 points | 0.10 to 3.02 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A4 | change | 2.73 points | 0.54 | 64 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A4 vs A6 | md | 1.06 points | -0.40 to 2.52 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A5 | change | 1.93 points | 0.57 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A5 vs A6 | md | 0.26 points | -1.24 to 1.77 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A6 | change | 1.67 points | 0.50 | 66 | treatment policy; modified itt; R0002409:Supplement Table S5 |
Physical functioning (any instrument) (22 lines; O24B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | change | 8.8 points | 1.68 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A1 | change | 2.36 points | 0.56 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A1 vs A6 | md | 2.3 points | -2.0 to 6.6 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A1 vs A6 | md | 1.35 points | -0.13 to 2.83 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A2 | change | 11.4 points | 1.54 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A2 | change | 3.08 points | 0.53 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A2 vs A6 | md | 4.9 points | 0.8 to 8.9 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A2 vs A6 | md | 2.07 points | 0.66 to 3.47 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A3 | change | 11.4 points | 1.55 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A3 | change | 3.17 points | 0.53 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A3 vs A6 | md | 4.9 points | 0.8 to 9.0 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A3 vs A6 | md | 2.16 points | 0.74 to 3.58 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A4 | change | 8.9 points | 1.78 | 64 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A4 | change | 2.92 points | 0.55 | 64 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A4 vs A6 | md | 2.4 points | -2.1 to 6.8 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A4 vs A6 | md | 1.91 points | 0.44 to 3.38 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A5 | change | 7.5 points | 1.62 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A5 | change | 1.86 points | 0.54 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A5 vs A6 | md | 1.0 points | -3.2 to 5.1 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A5 vs A6 | md | 0.86 points | -0.61 to 2.32 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A6 | change | 6.6 points | 1.39 | 66 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A6 | change | 1.01 points | 0.49 | 66 | treatment policy; modified itt; R0002409:Supplement Table S5 |
Health related quality of life total score (any instrument) (11 lines; O24C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 30 | A1 | change | 10.61 points | 1.65 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A1 vs A6 | md | 2.58 points | -1.63 to 6.78 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A2 | change | 12.57 points | 1.52 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A2 vs A6 | md | 4.53 points | 0.52 to 8.54 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A3 | change | 12.68 points | 1.55 | 52 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A3 vs A6 | md | 4.65 points | 0.59 to 8.70 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A4 | change | 11.05 points | 1.73 | 64 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A4 vs A6 | md | 3.01 points | -1.37 to 7.40 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A5 | change | 8.45 points | 1.62 | 53 | treatment policy; modified itt; R0002409:Supplement Table S5 | |
| 30 | A5 vs A6 | md | 0.42 points | -3.73 to 4.56 | treatment policy; modified itt; R0002409:Supplement Table S5 | ||
| 30 | A6 | change | 8.03 points | 1.38 | 66 | treatment policy; modified itt; R0002409:Supplement Table S5 |
Serious adverse events (6 lines; O25)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 2 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A2 | events | 3 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A3 | events | 1 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A4 | events | 0 / 64 | not stated; safety; R0002409:Table 3 | ||||
| A5 | events | 2 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A6 | events | 1 / 66 | not stated; safety; R0002409:Table 3 |
Discontinuation due to adverse events (6 lines; O26)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 4 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A2 | events | 1 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A3 | events | 4 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A4 | events | 10 / 64 | not stated; safety; R0002409:Table 3 | ||||
| A5 | events | 5 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A6 | events | 3 / 66 | not stated; safety; R0002409:Table 3 |
Nausea (6 lines; O27A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 18 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A2 | events | 25 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A3 | events | 25 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A4 | events | 41 / 64 | not stated; safety; R0002409:Table 3 | ||||
| A5 | events | 20 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A6 | events | 6 / 66 | not stated; safety; R0002409:Table 3 |
Vomiting (6 lines; O27B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 13 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A2 | events | 15 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A3 | events | 24 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A4 | events | 40 / 64 | not stated; safety; R0002409:Table 3 | ||||
| A5 | events | 28 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A6 | events | 8 / 66 | not stated; safety; R0002409:Table 3 |
Diarrhea (6 lines; O27C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 14 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A2 | events | 19 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A3 | events | 22 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A4 | events | 24 / 64 | not stated; safety; R0002409:Table 3 | ||||
| A5 | events | 26 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A6 | events | 12 / 66 | not stated; safety; R0002409:Table 3 |
Acute pancreatitis (6 lines; O29)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 52 | not stated; safety; pancreatitis; R0002409:Results | ||||
| A2 | events | 0 / 53 | not stated; safety; pancreatitis; R0002409:Results | ||||
| A3 | events | 0 / 52 | not stated; safety; pancreatitis; R0002409:Results | ||||
| A4 | events | 0 / 64 | not stated; safety; pancreatitis; R0002409:Results | ||||
| A5 | events | 0 / 53 | not stated; safety; pancreatitis; R0002409:Results | ||||
| A6 | events | 0 / 66 | not stated; safety; pancreatitis; R0002409:Results |
Suicidal ideation or behavior (6 lines; O35A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 52 | not stated; safety; R0002409:Results | ||||
| A2 | events | 0 / 53 | not stated; safety; R0002409:Results | ||||
| A3 | events | 0 / 52 | not stated; safety; R0002409:Results | ||||
| A4 | events | 0 / 64 | not stated; safety; R0002409:Results | ||||
| A5 | events | 0 / 53 | not stated; safety; R0002409:Results | ||||
| A6 | events | 0 / 66 | not stated; safety; R0002409:Results |
Death by suicide (6 lines; O35B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A2 | events | 0 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A3 | events | 0 / 52 | not stated; safety; R0002409:Table 3 | ||||
| A4 | events | 0 / 64 | not stated; safety; R0002409:Table 3 | ||||
| A5 | events | 0 / 53 | not stated; safety; R0002409:Table 3 | ||||
| A6 | events | 0 / 66 | not stated; safety; R0002409:Table 3 |